Results 301 to 310 of about 20,131,715 (394)

Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease. [PDF]

Nat Commun
Rothhaar P, Arand T, Seong HG, Heuss C, Tulessin M, Wang Z, Förster C, Schneider AC, Quistrebert J, Chai H, Reineke M, Benning L, Honegger J, Hofmann M, Thimme R, Timm J, STOPHCV investigators, Schnitzler P, Merle U, Shoukry NH, Bruneau J, Rodrigo C, Lloyd A, Bull RA, Ansari MA, Mogler C, McLauchlan J, Forns X, Pérez-Del-Pulgar S, Lohmann V.   +29 more
europepmc   +1 more source

Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability of Retreatment: The Glecaprevir/Pibrentasvir (Maviret®) Example [PDF]

Emma Warren, Belinda Castles, Gillian C. Sharratt, Aitor Arteaga   +3 more
openalex   +1 more source

Drug Repositioning of Pegbing® for Essential Thrombocythemia: Insights from PK/PD Modeling and Extrapolation

Clinical Pharmacology &Therapeutics, EarlyView.
Pegbing® (peginterferon alfa‐2b), a pegylated interferon‐alpha, is approved for the treatment of chronic hepatitis B (CHB) and C. One of its adverse effects is platelet (PLT) suppression. It is currently being repurposed for the treatment of essential thrombocythemia (ET), a rare myeloproliferative disorder characterized by abnormally elevated PLT ...
Weizhe Jian, Yalin Yin, Rong Chen, Junsheng Xue, Jianbo Gu, Zhengfang Du, Ruoyi He, Tianyan Zhou   +7 more
wiley   +1 more source

Prevalence of neurodevelopmental disorders in children with chronic hepatitis C in British Columbia. [PDF]

Can Liver J
Kishore SB, Guttman O.
europepmc   +1 more source

Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling

Developmental Dynamics, EarlyView.
Abstract Background Sporadic venous malformation (VM) is associated with the hyperactivating p.L914F mutation in TIE2, a receptor tyrosine kinase essential for vascular development. This mutation is not found in hereditary VM, suggesting incompatibility with life when expressed during early vascular development.
Lindsay J. Bischoff, Sandra Schrenk, Kara Soroko, Chhiring Sherpa, Ashok Arasu, Damien Reynaud, Elisa Boscolo   +6 more
wiley   +1 more source

Barriers and facilitators along the Hepatitis C reinfection journey: Qualitative interview study

Stuart A, Santamaria-Plaza C, Hibbert M, Simmons R, Reid L, Roberts M, Moore J, Desai M.   +7 more
europepmc   +1 more source

Determinants of hepatitis C virus treatment completion among Los Angeles County residents. [PDF]

BMC Infect Dis
Hernandez-Tamayo C, Stafylis C, Bhardwaj L, Shah RK, Becerra T, Bruce D, Saini R, Saremi N, Thomas I, Manansala-Tan K, Vij AP, Li A, Sudeep N, Gizamba J, Hosseini B, Navarro S, Ufret-Rivera S, Farias AJ, Klausner JD.   +18 more
europepmc   +1 more source

Health and Economic Impact of Periodic Hepatitis C Virus Testing Among People Who Inject Drugs [PDF]

Lin Zhu, Nathan W. Furukawa, W. Thompson, Marissa B Reitsma, Liisa M. Randall, Michelle Van Handel, Alice Asher, Eduardo Valverde, Benjamin P. Linas, Joshua A. Salomon   +9 more
openalex   +1 more source

Maternal Gestational Low‐Grade Inflammation and the Risk of Anorexia Nervosa in Daughters

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Prenatal exposures have been suggested to have a programming effect on neural and metabolic development, which may affect the risk of eating disorders. We investigated the association between prospectively measured maternal gestational high‐sensitivity C‐reactive protein (hs‐CRP), an established inflammatory biomarker, and subsequent
Emma Saure, Pyry N. Sipilä, Cynthia M. Bulik, Elina Santti, Heljä‐Marja Surcel, Antti Latvala, Anu Raevuori   +6 more
wiley   +1 more source

Decentralised Hepatitis C Management: A Simplified, Integrated Model of Care in a Primary Health Centre in Pakistan, August 2022-June 2023. [PDF]

J Viral Hepat
Mazzilli S, Aslam MK, Ahmed M, Wailly Y, Miazek M, Ashraf S, Ravji A, de Glanville WA, Isaakidis P.   +8 more
europepmc   +1 more source